ROBIN SHERRINGTON (EVP, Strategy & Innovation) sold 79.5% of their position (65.23K shares) of XENON PHARMACEUTICALS INC. on the open market

Open‑market sale worth $2.50M — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.

S · 3 sales

ROBIN SHERRINGTON

Filed: 9/2/2022ACC: 0001209191-22-048508

InsiderROBIN SHERRINGTONCIK 1619962

→

IssuerXENON PHARMACEUTICALS INC.CIK 1582313

Officer· EVP, Strategy & Innovation

Since Sep 2019

-72.92K

Net shares

Net seller

$2.80M

Total sold

Open market trades

0B · 3S

Total transactions

72.49K acquired · 145.41K disposed

Non-Derivative Transactions8

Common Shares

Direct

M · Option Exercise

+17.49K

Price / share

$2.67

Trade value

$46.69K

% of position

101.5%

8/31/2022

17.23K→34.72K

Common Shares

Direct

M · Option Exercise

+5K

Price / share

$4.75

Trade value

$23.75K

% of position

14.4%

8/31/2022

34.72K→39.72K

Common Shares

Direct

F · Tax Withholding

−1.57K

Price / share

$37.86

Trade value

$59.52K

% of position

4.0%

8/31/2022

39.72K→38.15K

Common Shares

Direct

S · Sale

−21.35K

Price / share

$38.57

Trade value

$823.55K

% of position

56.0%

8/31/2022

38.15K→16.80K

Common Shares

Direct

M · Option Exercise

+50K

Price / share

$4.75

Trade value

$237.50K

% of position

297.7%

9/1/2022

16.80K→66.80K

Common Shares

Direct

F · Tax Withholding

−6.12K

Price / share

$38.81

Trade value

$237.56K

% of position

9.2%

9/1/2022

66.80K→60.67K

Common Shares

Direct

S · Sale

−35.10K

Price / share

$38.03

Trade value

$1.33M

% of position

57.9%

9/1/2022

60.67K→25.57K

Common Shares

Direct

S · Sale

−8.78K

Price / share

$38.80

Trade value

$340.51K

% of position

34.3%

9/1/2022

25.57K→16.80K

Total

Net shares

−436.00

Net value

-$2.49M

Security	Date	Type	Shares	Price / Share	Trade Value	% of Position	Held Before	Held After
Common Shares Direct	8/31/2022	M · Option Exercise	+17.49K	$2.67	$46.69K	101.5%	17.23K	34.72K
Common Shares Direct	8/31/2022	M · Option Exercise	+5K	$4.75	$23.75K	14.4%	34.72K	39.72K
Common Shares Direct	8/31/2022	F · Tax Withholding	−1.57K	$37.86	$59.52K	4.0%	39.72K	38.15K
Common Shares Direct	8/31/2022	S · Sale	−21.35K	$38.57	$823.55K	56.0%	38.15K	16.80K
Common Shares Direct	9/1/2022	M · Option Exercise	+50K	$4.75	$237.50K	297.7%	16.80K	66.80K
Common Shares Direct	9/1/2022	F · Tax Withholding	−6.12K	$38.81	$237.56K	9.2%	66.80K	60.67K
Common Shares Direct	9/1/2022	S · Sale	−35.10K	$38.03	$1.33M	57.9%	60.67K	25.57K
Common Shares Direct	9/1/2022	S · Sale	−8.78K	$38.80	$340.51K	34.3%	25.57K	16.80K
Total			−436.00		-$2.49M

Derivative Transactions3

Stock Options (Right to Buy)

Direct

M · Option Exercise

Converts to

Common Shares

17.49K shares

−17.49K

Strike price

2.67

Held after

0.00

Exercisable

—

8/31/2022

Stock Options (Right to Buy)

Direct

M · Option Exercise

Converts to

Common Shares

5K shares

−5K

Strike price

4.75

Held after

0.00

Exercisable

—

8/31/2022

Stock Option (Right to Buy)

Direct

M · Option Exercise

Converts to

Common Shares

50K shares

−50K

Strike price

4.75

Held after

0.00

Exercisable

—

9/1/2022

Security	Converts To	Date	Type	Shares	Strike Price	Exercisable
Stock Options (Right to Buy) Direct	Common Shares17.49K shares	8/31/2022	M · Option Exercise	−17.49K	2.67	—
Stock Options (Right to Buy) Direct	Common Shares5K shares	8/31/2022	M · Option Exercise	−5K	4.75	—
Stock Option (Right to Buy) Direct	Common Shares50K shares	9/1/2022	M · Option Exercise	−50K	4.75	—